STOCK TITAN

Brainsway Ltd. (BWAY) Financials

BWAY
FY2024 annual
Revenue $41.0M +29.0% YoY
Net Income $2.9M +169.6% YoY
EPS (Diluted) Not reported for FY2024
Operating Cash Flow $10.3M +702.0% YoY
Market Cap $478.6M as of Oct 6, 2026
Price / Sales 11.7x on $41.0M revenue, FY2024
Price / Earnings 164x on $2.9M net income, FY2024
Price / Book 7.0x on $68.1M equity, Q2 FY2025

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 6, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2025, ended Jun 30, 2025 Reported Currency USD FYE December

Newest figures come from the 10-K for Q2 FY2025, filed Sep 30, 2025. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the BWAY SEC filings page.

Brainsway Ltd. (BWAY) reported $41.0M in revenue for fiscal year 2024, up 29.0% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 8 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI BWAY FY2024

BrainsWay moved from recurring losses to profitability in FY2024, while cash generation and financing changes reshaped its previously lightly leveraged balance sheet.

In FY2024, operating cash flow of $10.3M exceeded net income of $2.9M, indicating that reported earnings were accompanied by stronger cash generation. In FY2023, operating cash flow was only $1.3M despite a net loss of $4.2M, marking a shift from weak cash support for losses to cash conversion above accounting profit.

Revenue reached $41.0M in FY2024 and net margin turned positive at 7.1%, suggesting growth translated into earnings rather than remaining only top-line expansion. The figures establish an earnings inflection, but do not isolate whether mix, pricing, or cost structure drove the improvement.

Total assets rose to $94.3M while total liabilities reached $32.0M, so expansion involved a larger balance sheet without becoming debt-heavy. Even after long-term debt increased to $4.8M, debt-to-equity remained low at 0.1x, leaving the structure predominantly equity-funded.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score not available

Brainsway Ltd. does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial
4/8

Brainsway Ltd. passes 4 of 8 computable financial strength tests (1 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.

Earnings Quality Cash-Backed
3.53x

For every $1 of reported earnings, Brainsway Ltd. generates $3.53 in operating cash flow ($10.3M OCF vs $2.9M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

None of these metrics is reported for Q2 2025.

Cash & Balance Sheet

Cash & Debt
$67.9M
QoQ-2.1%

Brainsway Ltd. held $67.9M in cash against $5.2M in long-term debt as of Q2 2025.

Free Cash Flow

Not reported for Q2 2025.

Dividends Per Share

Not reported for Q2 2025.

Shares Outstanding

Not reported for Q2 2025.

Margins & Returns

None of these metrics is reported for Q2 2025.

Capital Allocation

None of these metrics is reported for Q2 2025.

BWAY Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

BWAY quarterly income statement
MetricQ2'2510-KQ4'2410-KQ4'2310-KQ4'2210-KQ4'2110-KQ4'2010-KQ3'2010-QQ4'1910-K

Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA, Interest Expense, Income Tax, Net Income, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).

BWAY Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

BWAY quarterly balance sheet
MetricQ2'2510-KQ4'2410-KQ4'2310-KQ4'2210-KQ4'2110-KQ4'2010-KQ3'2010-QQ4'1910-K
Total Assets$111.6M$94.3M+49.8%$63.0M-2.3%$64.5M-14.9%$75.7M+122.7%$34.0M-12.2%$34.4M-11.2%$38.7M+64.1%
Current Assets$89.0M$79.7M+43.6%$55.5M-4.5%$58.1M-11.2%$65.4M+169.4%$24.3M-15.7%$24.1M-16.5%$28.8M+113.9%
Cash & Equivalents$67.9M$69.3M+559.2%$10.5M-77.9%$47.6M+181.2%$16.9M-0.2%$17.0M-21.7%$15.8M-27.1%$21.7M+141.7%
Inventory$4.2M$4.4M+19.1%$3.7M-3.1%$3.8MN/AN/AN/AN/A
Total Liabilities$43.4M$32.0M+49.6%$21.4M+12.1%$19.1M+3.7%$18.4M+28.0%$14.4M-1.0%$14.5M-0.3%$14.5M-12.8%
Current Liabilities$25.5M$15.3M+57.2%$9.8M+19.9%$8.1M-10.2%$9.1M+33.3%$6.8M+1.2%$7.0M+3.8%$6.7M-19.4%
Non-Current Liabilities$17.9M$16.7M+43.2%$11.6M+6.3%$10.9M+17.1%$9.3M+23.3%$7.6M-2.8%$7.5M-3.9%$7.8M-6.2%
Long-Term Debt$5.2M$4.8M+1908.4%$239K-5.9%$254K0.0%$254K+4.5%$243K-63.3%N/A$663K
Total Equity$68.1M$62.3M+49.9%$41.6M-8.4%$45.4M-20.8%$57.3M+192.0%$19.6M-18.9%$19.9M-17.8%$24.2M+248.4%
Retained Earnings-$95.2M-$98.4M+2.9%-$101.3M-4.3%-$97.1M-15.9%-$83.8M-8.4%-$77.3M-7.5%-$76.9M-6.9%-$71.9M-16.8%

Not reported in any period shown, so not listed: Short-Term Investments, Accounts Receivable, Long-Term Investments, Goodwill.

BWAY Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

BWAY quarterly cash flow statement
MetricQ2'2510-KQ4'2410-KQ4'2310-KQ4'2210-KQ4'2110-KQ4'2010-KQ3'2010-QQ4'1910-K
Operating Cash FlowN/AN/AN/AN/AN/A$1.6M+233.3%N/A-$1.2M
Depreciation & AmortizationN/AN/AN/AN/AN/A-$833K+2.1%N/A-$851K
Capital ExpendituresN/AN/AN/AN/AN/A-$85K-74.9%N/A$338K
Free Cash FlowN/AN/AN/AN/AN/A$1.6M+199.2%N/A-$1.6M
Investing Cash FlowN/AN/AN/AN/AN/A$85K+121.5%N/A-$396K
Financing Cash FlowN/AN/AN/AN/AN/A-$750K-81.2%N/A-$414K

Not reported in any period shown, so not listed: Stock-Based Compensation, Dividends Paid, Share Buybacks.

BWAY Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

BWAY quarterly financial ratios
MetricQ2'2510-KQ4'2410-KQ4'2310-KQ4'2210-KQ4'2110-KQ4'2010-KQ3'2010-QQ4'1910-K
Current Ratio3.495.19-0.5x5.68-1.5x7.14-0.1x7.22+3.6x3.57-0.7x3.45-0.8x4.29+2.7x
Debt-to-Equity0.080.08+0.1x0.010.0x0.010.0x0.000.0x0.010.0x0.73+0.1x0.03-2.4x

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Return on Assets, Asset Turnover, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Brainsway Ltd. BWAY FY2024 $41.0M $2.9M 7.1% $478.6M —
Neuronetics, Inc. STIM FY2025 $149.2M -$39.0M -26.2% $167.6M 42/100
Viemed Healthcare, Inc. VMD FY2025 $270.3M $15.4M 5.7% $351.9M 65/100
Outset Medical, Inc. OM FY2025 $119.5M -$81.7M -68.3% $77.1M 61/100
Perspective Therapeutics, Inc. CATX FY2025 N/A -$103.1M N/A $293.4M —
NANO-X IMAGING LTD NNOX FY2025 $13.0M -$75.0M N/A $50.5M 54/100

Frequently Asked Questions

What is Brainsway Ltd.'s annual revenue?

Brainsway Ltd. (BWAY) reported $41.0M in total revenue for fiscal year 2024. This represents a 29.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Brainsway Ltd.'s revenue growing?

Brainsway Ltd. (BWAY) revenue grew by 29.0% year-over-year, from $31.8M to $41.0M in fiscal year 2024.

Is Brainsway Ltd. profitable?

Yes, Brainsway Ltd. (BWAY) reported a net income of $2.9M in fiscal year 2024, with a net profit margin of 7.1%.

As of fiscal year 2024, Brainsway Ltd. (BWAY) had $69.3M in cash and equivalents against $4.8M in long-term debt.

Brainsway Ltd. (BWAY) had a net profit margin of 7.1% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.

Brainsway Ltd. (BWAY) has a return on equity of 4.7% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.

Brainsway Ltd. (BWAY) generated $10.3M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.

Brainsway Ltd. (BWAY) had $94.3M in total assets as of fiscal year 2024, including both current and long-term assets.

Brainsway Ltd. (BWAY) had 38M shares outstanding as of fiscal year 2024.

Brainsway Ltd. (BWAY) had a current ratio of 5.19 as of fiscal year 2024, which is generally considered healthy.

Brainsway Ltd. (BWAY) had a debt-to-equity ratio of 0.08 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.

Brainsway Ltd. (BWAY) had a return on assets of 3.1% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

Brainsway Ltd. (BWAY) trades at 164x earnings, its market capitalization divided by net income of $2.9M net income, FY2024. The market capitalization is $478.6M as of Oct 6, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Brainsway Ltd. (BWAY) trades at 11.7x sales, its market capitalization divided by revenue of $41.0M revenue, FY2024. The market capitalization is $478.6M as of Oct 6, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Brainsway Ltd. (BWAY) has a Piotroski F-Score of 4 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Brainsway Ltd. (BWAY) has an earnings quality ratio of 3.53x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Back to top